6 results
The Eurotherm3235trial will examine the relationship between ICP reduction after TBI using therapeutichypothermia and patient outcome.
This study has been transitioned to CTIS with ID 2024-514488-24-01 check the CTIS register for the current data. Primary Objective: To determine the safety and efficacy of 6000 IU Cinryze in patients with moderate and severe TBI (GCS <13 with…
The aim of this PMCF study is to confirm the clinical safety and performance aspects of intracranial catheter placements forthe medical indications, hydrocephalus of any origin or ICP elevation. The study design requires determination of…
In a phase II study we will evaluate safety and proof-of-concept of acetazolamide in patients with aneurysmal SAH. The primary aim of this study is to evaluate whether acetazolamide improves cerebral perfusion as measured with magnetic resonance…
Main aim: We will assess whether the new intervention protocol provides a greater percentage of time during which CPP is within 5 mmHg of calculated individual and flexible CPP (CPPopt). This window has been chosen based on past studies which show…
The primary objective of this study is to determine the effect of changes in transpulmonary pressure on ICP in severe TBI patients. Secondary objectives are to study the effect of change in transpulmonary pressure on cerebral blood flow velocity,…